|
|
三叶因子家族在胃癌中的研究进展
|
Abstract:
三叶因子家族(TFF)是一类具有三叶因子结构域的小的分泌蛋白，因为它们具有较高的氨基酸序列同一性和二硫化物桥的数量和定位。二硫化物键的特定模式形成了典型的三叶形状，称为三叶结构域。三叶因子家族具有耐酶、耐热和耐酸等特性，研究表明，TFFs与多种肿瘤之间存在密切关联，近年来的一些研究正在逐步揭示这一点。TFFs的表达在多种恶性肿瘤中均有上调，包括胃癌、结肠癌、肝细胞癌、乳腺癌、前列腺癌等。此外，这些肿瘤组织或患者血清中的TFFs水平与恶性程度和预后密切相关。TFFs通过增强细胞增殖、侵袭、转移和血管生成以及抑制细胞凋亡来促进肿瘤的发生和转移。但主要在胃肠道中的研究较多，以下就三叶因子的蛋白质结构、组织表达和分布等方面进行综述。为今后更好地了解该肽家族及其在胃癌中的诊断及治疗效果提供指导。
The Trefoil Factor Family (TFF) is a class of small secreted proteins with trefoil factor domains because of their high amino acid sequence identity and number and localization of disulfide bridges. The specific pattern of disulphide bonds forms the typical trefoil shape, called the trefoil domain. The trefoil factor family is characterized by enzyme, heat and acid resistance, which has shown a close association between TFFs and multiple tumors, and some recent studies are revealing this step by step. The expression levels of TFFs are significantly increased in several types of malignant tumors, such as gastric cancer, colon cancer, hepatocellular carcinoma, breast cancer, and prostate cancer, among others. Additionally, the concentration of TFFs found in tumor tissues or patient serum correlates closely with the severity of malignancy and overall prognosis. TFFs facilitate tumor development and spread by promoting cell proliferation, invasion, metastasis, and angiogenesis, as well as inhibiting apoptosis. However, there are many studies mainly in the gastrointestinal tract. The protein structure, tissue expression and distribution of trefoil factor are reviewed below. It provides guidance for a better understanding of this peptide family and its diagnosis and treatment effect in gastric cancer in the future.
| [1] | 邬昊, 吕青. 全球及中国乳腺癌的流行病学趋势及防控启示: 2018-2022年《全球癌症统计报告》解读[J]. 中国普外基础与临床杂志 ,2024, 31(7): 796-802. |
| [2] | 尹希, 牛建, 史海水. 三叶因子3的中枢功能研究进展[J]. 中国药物依赖性杂志, 2013, 22(6): 408-411. |
| [3] | Riemer, J., Bulleid, N. and Herrmann, J.M. (2009) Disulfide Formation in the ER and Mitochondria: Two Solutions to a Common Process. Science, 324, 1284-1287. https://doi.org/10.1126/science.1170653 |
| [4] | 昝香怡. 基于自然人群的横断面队列在胃癌高风险地区用血清标志物筛查胃癌及癌前病变的效能探讨[D]: [博士学位论文]. 兰州: 兰州大学临床医学, 2022. |
| [5] | Babyatsky, M., deBeaumont, M., Thim, L. and Podolsky, D. (1996) Oral Trefoil Peptides Protect against Ethanol-and Indomethacin-Induced Gastric Injury in Rats. Gastroenterology, 110, 489-497. https://doi.org/10.1053/gast.1996.v110.pm8566596 |
| [6] | Pera, M., Heppell, J., Poulsom, R., Teixeira, F.V. and Williams, J. (2001) Ulcer Associated Cell Lineage Glands Expressing Trefoil Peptide Genes Are Induced by Chronic Ulceration in Ileal Pouch Mucosa. Gut, 48, 792-796. https://doi.org/10.1136/gut.48.6.792 |
| [7] | Ge, Y., Zhang, J., Cao, J., Wu, Q., Sun, L., Guo, L., et al. (2012) TFF1 Inhibits Proliferation and Induces Apoptosis of Gastric Cancer Cells in Vitro. Bosnian Journal of Basic Medical Sciences, 12, 74-81. https://doi.org/10.17305/bjbms.2012.2499 |
| [8] | Bossenmeyer-Pourié, C., Kannan, R., Ribieras, S., Wendling, C., Stoll, I., Thim, L., et al. (2002) The Trefoil Factor 1 Participates in Gastrointestinal Cell Differentiation by Delaying G1-S Phase Transition and Reducing Apoptosis. The Journal of Cell Biology, 157, 761-770. https://doi.org/10.1083/jcb200108056 |
| [9] | Ebert, M.P.A., Hoffmann, J., Haeckel, C., Rutkowski, K., Schmid, R.M., Wagner, M., et al. (1999) Induction of TFF1 Gene Expression in Pancreas Overexpressing Transforming Growth Factor Alpha. Gut, 45, 105-111. https://doi.org/10.1136/gut.45.1.105 |
| [10] | Jørgensen, K.H., Thim, L. and Jacobsen, H.E. (1982) Pancreatic Spasmolytic Polypeptide (PSP): I. Preparation and Initial Chemical Characterization of a New Polypeptide from Porcine Pancreas. Regulatory Peptides, 3, 207-219. https://doi.org/10.1016/0167-0115(82)90126-4 |
| [11] | Jørgensen, K.D., Diamant, B., Jørgensen, K.H. and Thim, L. (1982) Pancreatic Spasmolytic Polypeptide (PSP): III. Pharmacology of a New Porcine Pancreatic Polypeptide with Spasmolytic and Gastric Acid Secretion Inhibitory Effects. Regulatory Peptides, 3, 231-243. https://doi.org/10.1016/0167-0115(82)90128-8 |
| [12] | Hoffmann, W. (2015) TFF2, a MUC6-Binding Lectin Stabilizing the Gastric Mucus Barrier and More (Review). International Journal of Oncology, 47, 806-816. https://doi.org/10.3892/ijo.2015.3090 |
| [13] | Kouznetsova, I., Kalinski, T., Meyer, F. and Hoffmann, W. (2011) Self-Renewal of the Human Gastric Epithelium: New Insights from Expression Profiling Using Laser Microdissection. Molecular BioSystems, 7, 1105-1112. https://doi.org/10.1039/c0mb00233j |
| [14] | Quante, M., Marrache, F., Goldenring, J.R. and Wang, T.C. (2010) TFF2 mRNA Transcript Expression Marks a Gland Progenitor Cell of the Gastric Oxyntic Mucosa. Gastroenterology, 139, 2018-2027.e2. https://doi.org/10.1053/j.gastro.2010.08.003 |
| [15] | Jeffrey, G.P., Oates, P.S., Wang, T.C., Babyatsky, M.W. and Brand, S.J. (1994) Spasmolytic Polypeptide: A Trefoil Peptide Secreted by Rat Gastric Mucous Cells. Gastroenterology, 106, 336-345. https://doi.org/10.1016/0016-5085(94)90590-8 |
| [16] | Hanisch, F., Bonar, D., Schloerer, N. and Schroten, H. (2014) Human Trefoil Factor 2 Is a Lectin That Binds α-Glcnac-Capped Mucin Glycans with Antibiotic Activity against Helicobacter Pylori. Journal of Biological Chemistry, 289, 27363-27375. https://doi.org/10.1074/jbc.m114.597757 |
| [17] | Playford, R.J., Marchbank, T., Chinery, R., Evison, R., Pignatelli, M., Boulton, R.A., et al. (1995) Human Spasmolytic Polypeptide Is a Cytoprotective Agent That Stimulates Cell Migration. Gastroenterology, 108, 108-116. https://doi.org/10.1016/0016-5085(95)90014-4 |
| [18] | Fujimoto, K., Fujii, G., Taguchi, K., Yasuda, K., Matsuo, Y., Hashiyama, A., et al. (2015) Involvement of Trefoil Factor Family 2 in the Enlargement of Intestinal Tumors in Apcmin/+ Mice. Biochemical and Biophysical Research Communications, 463, 859-863. https://doi.org/10.1016/j.bbrc.2015.06.025 |
| [19] | Ortiz-Masiá, D., Hernández, C., Quintana, E., Veiázquez, M., Cebrián, S., Riaño, A., et al. (2009) Inos‐Derived Nitric Oxide Mediates the Increase in TFF2 Expression Associated with Gastric Damage: Role of HIF‐1. The FASEB Journal, 24, 136-145. https://doi.org/10.1096/fj.09-137489 |
| [20] | Aikou, S., Ohmoto, Y., Gunji, T., Matsuhashi, N., Ohtsu, H., Miura, H., et al. (2011) Tests for Serum Levels of Trefoil Factor Family Proteins Can Improve Gastric Cancer Screening. Gastroenterology, 141, 837-845.e7. https://doi.org/10.1053/j.gastro.2011.05.040 |
| [21] | Peterson, A.J., Menheniott, T.R., O’Connor, L., Walduck, A.K., Fox, J.G., Kawakami, K., et al. (2010) Helicobacter Pylori Infection Promotes Methylation and Silencing of Trefoil Factor 2, Leading to Gastric Tumor Development in Mice and Humans. Gastroenterology, 139, 2005-2017. https://doi.org/10.1053/j.gastro.2010.08.043 |
| [22] | Muskett, F.W., May, F.E.B., Westley, B.R. and Feeney, J. (2003) Solution Structure of the Disulfide-Linked Dimer of Human Intestinal Trefoil Factor (TFF3): The Intermolecular Orientation and Interactions Are Markedly Different from Those of Other Dimeric Trefoil Proteins. Biochemistry, 42, 15139-15147. https://doi.org/10.1021/bi030182k |
| [23] | Jahan, R., Shah, A., Kisling, S.G., Macha, M.A., Thayer, S., Batra, S.K., et al. (2020) Odyssey of Trefoil Factors in Cancer: Diagnostic and Therapeutic Implications. Biochimica et Biophysica Acta (BBA)—Reviews on Cancer, 1873, Article ID: 188362. https://doi.org/10.1016/j.bbcan.2020.188362 |
| [24] | Yang, Y., Lin, Z., Lin, Q., Bei, W. and Guo, J. (2022) Pathological and Therapeutic Roles of Bioactive Peptide Trefoil Factor 3 in Diverse Diseases: Recent Progress and Perspective. Cell Death & Disease, 13, Article No. 62. https://doi.org/10.1038/s41419-022-04504-6 |
| [25] | Chan, M.W.Y., Chan, V.Y.W., Leung, W.K., Chan, K.K., To, K.F., Sung, J.J.Y., et al. (2005) Anti-Sense Trefoil Factor Family-3 (intestinal Trefoil Factor) Inhibits Cell Growth and Induces Chemosensitivity to Adriamycin in Human Gastric Cancer Cells. Life Sciences, 76, 2581-2592. https://doi.org/10.1016/j.lfs.2004.11.014 |
| [26] | Efstathiou, J.A., Noda, M., Rowan, A., Dixon, C., Chinery, R., Jawhari, A., et al. (1998) Intestinal Trefoil Factor Controls the Expression of the Adenomatous Polyposis Coli-Catenin and the E-Cadherin-Catenin Complexes in Human Colon Carcinoma Cells. Proceedings of the National Academy of Sciences of the United States of America, 95, 3122-3127. https://doi.org/10.1073/pnas.95.6.3122 |
| [27] | Yio, X., Zhang, J., Babyatsky, M., Chen, A., Lin, J., Fan, Q., et al. (2005) Trefoil Factor Family-3 Is Associated with Aggressive Behavior of Colon Cancer Cells. Clinical & Experimental Metastasis, 22, 157-165. https://doi.org/10.1007/s10585-005-6615-z |
| [28] | Taupin, D.R., Kinoshita, K. and Podolsky, D.K. (2000) Intestinal Trefoil Factor Confers Colonic Epithelial Resistance to Apoptosis. Proceedings of the National Academy of Sciences of the United States of America, 97, 799-804. https://doi.org/10.1073/pnas.97.2.799 |
| [29] | Chan, V.Y.W., Chan, M.W.Y., Leung, W., Leung, P., Sung, J.J.Y. and Chan, F.K.L. (2005) Intestinal Trefoil Factor Promotes Invasion in Non-Tumorigenic Rat-2 Fibroblast Cell. Regulatory Peptides, 127, 87-94. https://doi.org/10.1016/j.regpep.2004.10.016 |
| [30] | Dhar, D.K., Wang, T.C., Tabara, H., Tonomoto, Y., Maruyama, R., Tachibana, M., et al. (2005) Expression of Trefoil Factor Family Members Correlates with Patient Prognosis and Neoangiogenesis. Clinical Cancer Research, 11, 6472-6478. https://doi.org/10.1158/1078-0432.ccr-05-0671 |
| [31] | Rodrigues, S., Aken, E., Bocxlaer, S., Attoub, S., Nguyen, Q., Bruyneel, E., et al. (2003) Trefoil Peptides as Proangiogenic Factors in Vivo and in Vitro: Implication of Cyclooxygenase‐2 and EGF Receptor Signaling. The FASEB Journal, 17, 7-16. https://doi.org/10.1096/fj.02-0201com |
| [32] | Im, S., Yoo, C., Jung, J., Choi, H.J., Yoo, J. and Kang, C.S. (2013) Reduced Expression of TFF1 and Increased Expression of TFF3 in Gastric Cancer: Correlation with Clinicopathological Parameters and Prognosis. International Journal of Medical Sciences, 10, 133-140. https://doi.org/10.7150/ijms.5500 |
| [33] | Emami, S., Rodrigues, S., Rodrigue, C.M., Le Floch, N., Rivat, C., Attoub, S., et al. (2004) Trefoil Factor Family (TFF) Peptides and Cancer Progression. Peptides, 25, 885-898. https://doi.org/10.1016/j.peptides.2003.10.019 |
| [34] | Guleng, B., Han, J., Yang, J., Huang, Q., Huang, J., Yang, X., et al. (2011) TFF3 Mediated Induction of VEGF via Hypoxia in Human Gastric Cancer SGC-7901 Cells. Molecular Biology Reports, 39, 4127-4134. https://doi.org/10.1007/s11033-011-1195-2 |
| [35] | Christine, R., Sylvie, R., Erik, B., Geneviève, P., Amélie, R., Gérard, R., et al. (2005) Implication of STAT3 Signaling in Human Colonic Cancer Cells during Intestinal Trefoil Factor 3 (TFF3)—And Vascular Endothelial Growth Factor-Mediated Cellular Invasion and Tumor Growth. Cancer Research, 65, 195-202. https://doi.org/10.1158/0008-5472.195.65.1 |
| [36] | Li, Y., Sun, Z., Liu, K., Qiu, W., Yao, R., Feng, T., et al. (2014) Prognostic Significance of the Co-Expression of Nucleophosmin and Trefoil Factor 3 in Postoperative Gastric Cancer Patients. Molecular and Clinical Oncology, 2, 1055-1061. https://doi.org/10.3892/mco.2014.351 |
